What is Alzamend Neuro, Inc. Common Stock's Market Cap?

Alzamend Neuro, Inc. Common Stock's Market Cap is $8.0M, based on as-reported figures from SEC (XBRL) filings.

What is Alzamend Neuro, Inc. Common Stock's Enterprise Value?

Alzamend Neuro, Inc. Common Stock's Enterprise Value is $7.3M, based on as-reported figures from SEC (XBRL) filings.

What is Alzamend Neuro, Inc. Common Stock's EV / EBITDA?

Alzamend Neuro, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Alzamend Neuro, Inc. Common Stock's Net Income (TTM)?

Alzamend Neuro, Inc. Common Stock's Net Income (TTM) is -$8.8M, based on as-reported figures from SEC (XBRL) filings.

What is Alzamend Neuro, Inc. Common Stock's EBITDA?

Alzamend Neuro, Inc. Common Stock's EBITDA is -$8.7M, based on as-reported figures from SEC (XBRL) filings.

What is Alzamend Neuro, Inc. Common Stock's Diluted EPS (TTM)?

Alzamend Neuro, Inc. Common Stock's Diluted EPS (TTM) is -1.83, based on as-reported figures from SEC (XBRL) filings.

What is Alzamend Neuro, Inc. Common Stock's Net Debt?

Alzamend Neuro, Inc. Common Stock's Net Debt is -$710.7K, based on as-reported figures from SEC (XBRL) filings.

Alzamend Neuro, Inc. Common Stock (ALZN) Financial Statements

Alzamend Neuro, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00ZMXG7N7

XNAS · usd

1.68▲ 0.02 (1.20%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.66

Day's Range1.62 – 1.72

52-Week Range0.84 – 2.68

Volume31.2K

Avg Volume77.3K

Share Statistics

Shares Outstanding

Employees7

ExchangeXNAS

Listed2021-06-15

Share count as of July 22, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Alzamend Neuro, Inc. Common Stock (ALZN)

What is Alzamend Neuro, Inc. Common Stock's Market Cap?: Alzamend Neuro, Inc. Common Stock's Market Cap is $8.0M, based on as-reported figures from SEC (XBRL) filings.
What is Alzamend Neuro, Inc. Common Stock's Enterprise Value?: Alzamend Neuro, Inc. Common Stock's Enterprise Value is $7.3M, based on as-reported figures from SEC (XBRL) filings.
What is Alzamend Neuro, Inc. Common Stock's EV / EBITDA?: Alzamend Neuro, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Alzamend Neuro, Inc. Common Stock's Net Income (TTM)?: Alzamend Neuro, Inc. Common Stock's Net Income (TTM) is -$8.8M, based on as-reported figures from SEC (XBRL) filings.
What is Alzamend Neuro, Inc. Common Stock's EBITDA?: Alzamend Neuro, Inc. Common Stock's EBITDA is -$8.7M, based on as-reported figures from SEC (XBRL) filings.
What is Alzamend Neuro, Inc. Common Stock's Diluted EPS (TTM)?: Alzamend Neuro, Inc. Common Stock's Diluted EPS (TTM) is -1.83, based on as-reported figures from SEC (XBRL) filings.
What is Alzamend Neuro, Inc. Common Stock's Net Debt?: Alzamend Neuro, Inc. Common Stock's Net Debt is -$710.7K, based on as-reported figures from SEC (XBRL) filings.